Context Therapeutics Inc. began using LinkedIn for public communication.
2 reports, 1 independent
Updated Aug 27
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Context Therapeutics Inc. began using LinkedIn for public communication.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Context Therapeutics Inc. started using LinkedIn for company updates.1 source
Aligos Therapeutics started using LinkedIn for public communication.1 source
Keep exploring
The entities involved
-
LinkedIn
American social networking website for people in professional occupations
-
Aligos Therapeutics, Inc.
Nothing else this week.
Related events
- Pelthos Therapeutics Inc. began using LinkedIn for investor outreach on July 1, 2026.
- Pelthos Therapeutics Inc. followed another company on LinkedIn on November 1, 2026.
- A company with FDA-approved therapies used LinkedIn for information and its board approved a stock award for CFO hiring.
- Syndax Pharmaceuticals has FDA-approved therapies in its pipeline and uses LinkedIn for company communication.
- Netskope began using LinkedIn and Instagram for corporate communication.
Coverage
Newest first; wire copies grouped- GlobeNewswireContext Therapeutics to Participate in Upcoming Investor Conferences PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-
- GlobeNewswireAligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”,